RNA5SP518

Q-omics provides the consensus-scored RNA5SP518 profile across patient tissues and cancer cell-line models. RNA5SP518 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in STAD. Additionally, RNA5SP518 RNA expression shows 1,558 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight STAD as cancer lineages where RNA5SP518 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes RNA5SP518 survival associations across molecular data types. RNA5SP518 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RNA5SP518 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	STAD (63)	view →

This table ranks reproducible RNA5SP518 RNA expression–survival associations across cancer types. High RNA5SP518 expression shows unfavorable associations in STAD. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for RNA5SP518 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.052	0.496	<.001	63	view →

Pink = unfavorable, green = favorable. all 1 lineages →

RNA5SP518-STAD (OS)

Explore this curve interactively →